Caesarstone Ltd.
CSTE News Today: Stay Updated with the Latest Caesarstone Ltd. News in Real Time
Find CSTE news now at Meyka AI. Stay informed with the latest Caesarstone Ltd. stocks updates, including price news, market analysis, and expert insights.
STEV Stock Surges 9900% on PNK Exchange, Stevia Corp. Gains Momentum
STEV stock explodes 9900% to $0.0001 on PNK. Stevia Corp. shows extreme volatility with massive one-day gains amid agricultural sector activity.
Claude Mythos: A Powerful AI That Can Break Code Instantly
Artificial intelligence is moving fast in 2026. In April 2026, new reports around Anthropic’s Claude Mythos model have sparked major attention in the tech world. This advanced AI is said to go beyond coding help and can analyze and break complex code structures in seconds. Experts are calling it a major shift in cybersecurity tools….
Trump Threatens Germany Troop Cuts April 30: NATO Row Escalates
Trump threatens US troop cuts in Germany amid NATO tensions over Iran policy and defense spending commitments.
WNEB Maintains Buy Rating as Seaport Raises Price Target April 2026
Seaport Global maintains Buy rating on WNEB, raising price target to $16 from $15. Western New England Bancorp holds steady.
IFX.SW Stock Bounces Back: Infineon Technologies AG Down 1.29% on April 30
IFX.SW trades at CHF33.54 on SIX, down 1.29% intraday, showing oversold bounce signals amid semiconductor sector volatility.
4288.T Stock Plunges 20.7% on April 30 as Asgent Faces Losses
Asgent Inc. (4288.T) drops 20.7% to ¥700 on JPX. Negative earnings, weak fundamentals, and D+ rating signal trouble for the Tokyo security firm.
Spotify Stock April 30: Taylor Swift’s Clause Pays Artists Millions
Taylor Swift’s Spotify clause triggers $1.4B payout to UMG artists, reshaping streaming economics for musicians.
0005.HK Stock Holds Steady at HK$140.2 Ahead of May Earnings
HSBC Holdings plc (0005.HK) trades flat at HK$140.2 on HKSE. Earnings announcement May 5. PE ratio 14.97, dividend yield 4.16%.
Eli Lilly ($LLY) Raises Annual Forecasts as GLP-1 Drugs Fuel Growth
Eli Lilly and Company ($LLY) raised its full-year 2026 forecast in April 2026 after strong demand for its GLP-1 drugs. The company reported better-than-expected Q1 2026 results, driven by rapid sales of Mounjaro and Zepbound. These medicines are reshaping the obesity and diabetes market worldwide. Investor confidence has surged as growth momentum continues. The update…